Viewing Study NCT02933320


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-02-24 @ 5:43 AM
Study NCT ID: NCT02933320
Status: COMPLETED
Last Update Posted: 2021-07-08
First Post: 2016-09-26
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia
Sponsor: Cancer Research UK
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-10-27
Start Date Type: ACTUAL
Primary Completion Date: 2020-03-19
Primary Completion Date Type: ACTUAL
Completion Date: 2020-03-19
Completion Date Type: ACTUAL
First Submit Date: 2016-09-26
First Submit QC Date: None
Study First Post Date: 2016-10-14
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2021-03-21
Results First Submit QC Date: None
Results First Post Date: 2021-07-08
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-06-17
Last Update Post Date: 2021-07-08
Last Update Post Date Type: ACTUAL